UPDATED: Hedge fund aims to oust Depomed board for ‘troubling record’

Eric Palmer

If thought it was free to chart its own course after foiling a takeover by Horizon Pharma last year, it can think again. A practiced in the art of takeovers has set its sights on the Newark, CA-based drugmaker.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2017 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS